Alfuzosin D7
| Product Name | Alfuzosin D7 |
|---|---|
| Alternate Names | Alfuzosin Stable Isotopes, Stable Isotopes of Alfuzosin |
| CAT No. | CS-O-10083 |
| CAS No. | 1133386-93-2 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 396.49 g/mol |
| Mol. For. | C₁₉H₂₀D₇N₅O₄ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Alfuzosin |
| Purity | Not less than 95 % |
| Smileys | NC1=NC(N(C)CCCNC(C2([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])O2)=O)=NC3=C1C=C(OC)C(OC)=C3 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Alfuzosin D7 is a deuterated form of the medication alfuzosin, which is primarily used to treat symptoms associated with an enlarged prostate gland, such as difficulty urinating and frequent urination. Alfuzosin D7 is commonly used in research and development studies as an analytical standard to determine the pharmacokinetics of alfuzosin in biological fluids.
The chemical structure of Alfuzosin D7 is similar to alfuzosin, with the only difference being the presence of seven deuterium atoms in the molecular structure. Deuterium is a stable isotope of hydrogen, and its presence in Alfuzosin D7 enhances the accuracy of the analytical measurements due to its unique mass properties.
Alfuzosin D7 is typically administered orally in the form of extended-release tablets, with a recommended dosage of 10 mg once daily. The medication works by relaxing the muscles in the prostate gland and bladder neck, thereby improving urine flow and reducing the symptoms associated with an enlarged prostate.
Studies have shown that Alfuzosin D7 is well-tolerated by most patients, with minimal side effects such as dizziness, headache, and fatigue. However, it is important to note that alfuzosin may interact with other medications, such as alpha-blockers, nitrates, and antihypertensives, and should only be used under the supervision of a healthcare professional.
Get an Instant Quote
Related Compounds
Alfuzosin D7 Hydrochloride | Alfuzosin hydrochloride D3 | N2-Methyl Alfuzosin-d7 Hydrochloride | Alfuzosin hydrochloride D6 | Alfuzosin 13CD3 |